ACR Convergence 2025| Video: Rheum for Everyone, Episode 26—Ableism

An official publication of the ACR and the ARP serving rheumatologists and rheumatology professionals

  • Conditions
    • Axial Spondyloarthritis
    • Gout and Crystalline Arthritis
    • Myositis
    • Osteoarthritis and Bone Disorders
    • Pain Syndromes
    • Pediatric Conditions
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
    • Systemic Sclerosis
    • Vasculitis
    • Other Rheumatic Conditions
  • FocusRheum
    • ANCA-Associated Vasculitis
    • Axial Spondyloarthritis
    • Gout
    • Lupus Nephritis
    • Psoriatic Arthritis
    • Rheumatoid Arthritis
    • Sjögren’s Disease
    • Systemic Lupus Erythematosus
  • Guidance
    • Clinical Criteria/Guidelines
    • Ethics
    • Legal Updates
    • Legislation & Advocacy
    • Meeting Reports
      • ACR Convergence
      • Other ACR meetings
      • EULAR/Other
    • Research Rheum
  • Drug Updates
    • Analgesics
    • Biologics/DMARDs
  • Practice Support
    • Billing/Coding
    • EMRs
    • Facility
    • Insurance
    • Technology
      • Information Technology
      • Apps
    • QA/QI
    • Workforce
  • Opinion
    • Patient Perspective
    • Profiles
    • Rheuminations
      • Video
    • Speak Out Rheum
  • Career
    • ACR ExamRheum
    • Awards
    • Career Development
      • Education & Training
    • Certification
  • ACR
    • ACR Home
    • ACR Convergence
    • ACR Guidelines
    • Journals
      • ACR Open Rheumatology
      • Arthritis & Rheumatology
      • Arthritis Care & Research
    • From the College
    • Events/CME
    • President’s Perspective
  • Search

How Lymphatic Drainage Controls Synovial Inflammation

Michael Cammarata, MD  |  November 2, 2025

In active synovium of TNF transgenic mice, telocytes are lost, and can be restored with anti-TNF therapy. Electron and confocal microscopy imaging have demonstrated intimate interactions between telocytes and mast cells along lymphatic vessels, leading the team to hypothesize that telocyte signaling to mast cells is essential to histamine release and lymphatic vessel contraction. They further hypothesized and subsequently demonstrated that knocking out telocytes led to a collapsed lymphatic phenotype due to loss of contractile signaling. Telocyte-deficient mice also had a more persistent inflammatory arthritis with greater erosions in a zymosan-induced inflammatory arthritis mouse model.

To summarize the current working model of the synovial lymphatic system and how it drains the joint, Dr. Schwarz said, “there is a telocyte network that extends from telopod to telopod, that parallels the lymphatic vessels from the synovium all the way up to the collecting vessel, where it ends by integrating into mast cells.” Telocytes in the synovium sense osmotic pressure and communicate with mast cells to degranulate and result in a tonic contraction of the vessel.

ad goes here:advert-1
ADVERTISEMENT
SCROLL TO CONTINUE

The model posited two important assumptions, and both were validated experimentally. First, the existence of the network was confirmed via confocal microscopy. Second, investigators demonstrated that telocytes are exquisitely sensitive to osmotic pressure using an in-vitro culture model.

Conclusions

Dr. Schwarz closed with a compelling clinical question: Can exercise maintain or improve telocytes and the synovial lymphatic systemic in chronic inflammatory arthritis? In a mouse model, the answer appears to be yes. He also outlined a working yet intriguing hypothesis that telocytes may differentiate into pro-fibrotic fibroblast like synoviocytes, further contributing to the pathogenesis of inflammatory arthritis.

ad goes here:advert-2
ADVERTISEMENT
SCROLL TO CONTINUE

During the Q&A, attendees posited that there is likely wider application of this model beyond arthritis, such as photosensitivity in lupus. Dr. Schwarz agreed, adding that a similar process may underlie neural injury in multiple sclerosis.

Although further investigation is needed, the work of Dr. Schwarz and his laboratory team highlighted an important piece of the inflammatory arthritis puzzle—one that may someday be a novel therapeutic target.


Michael Cammarata, MD, RhMSUS, is an assistant professor of medicine at the Johns Hopkins University School of Medicine in Baltimore, Md.

 

References

  1. Bouta EM, Bell RD, Rahimi H, et al. Targeting lymphatic function as a novel therapeutic intervention for rheumatoid arthritis. Nat Rev Rheumatol. 2018;14(2):94–106. 
  2. Proulx ST, Kwok E, You Z, et al. Longitudinal assessment of synovial, lymph node, and bone volumes in inflammatory arthritis in mice by in vivo magnetic resonance imaging and microfocal computed tomography. Arthritis Rheum. 2007;56(12):4024–4037. 
  3. Li J, Kuzin I, Moshkani S, et al. Expanded CD23(+)/CD21(hi) B cells in inflamed lymph nodes are associated with the onset of inflammatory-erosive arthritis in TNF-transgenic mice and are targets of anti-CD20 therapy. J Immunol. 2010;184(11):6142–6150.
  4. Li J, Ju Y, Bouta EM, et al. Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow. Arthritis Rheum. 2013;65(1):130–138.
  5. Rahimi H, Dieudonne G, Kheyfits V, et al. Relationship Between Lymph Node Volume and Pain Following Certolizumab Therapy for Rheumatoid Arthritis Flare: A Pilot Study. Clin Med Insights Arthritis Musculoskelet Disord. 2016;9:203–208.
  6. Bell RD, Rahimi H, Kenney HM, et al. Altered Lymphatic Vessel Anatomy and Markedly Diminished Lymph Clearance in Affected Hands of Patients With Active Rheumatoid Arthritis. Arthritis Rheumatol. 2020;72(9):1447–1455.
  7. Scallan JP, Wolpers JH, Davis MJ. Constriction of isolated collecting lymphatic vessels in response to acute increases in downstream pressure. J Physiol. 2013;591(2):443–459.
  8. Scallan JP, Bouta EM, Rahimi H, et al. Ex vivoDemonstration of Functional Deficiencies in Popliteal Lymphatic Vessels From TNF-Transgenic Mice With Inflammatory Arthritis. Front Physiol. 2021;12:745096. 
  9. Peng Y, Kenney HM, de Mesy Bentley KL, et al. Distinct mast cell subpopulations within and around lymphatic vessels regulate lymph flow and progression of inflammatory-erosive arthritis in TNF-transgenic mice. Front Immunol. 2023;14:1275871.

Page: 1 2 3 4 | Single Page
Share: 

Filed under:ACR ConvergenceConditionsMeeting ReportsResearch RheumRheumatoid Arthritis Tagged with:ACR Convergence 2025ACR Convergence 2025 - RAlymphaticsmast cellsynovitistelocytes

Related Articles
    Figures 1 & 2: Transverse and longitudinal ultrasound views, respectively, of the left posterior knee, revealing a cystic mass with heterogeneous internal echotexture and no stalk.

    Ultrasound Aids Diagnosis of Man with Knee Pain & Swelling

    November 17, 2019

    A 56-year-old automobile mechanic was referred to our rheumatology service by his orthopedist to evaluate left posterior knee pain and swelling that had been present for three months. The patient had undergone bilateral total knee arthroplasties (TKAs) for sports-related osteo­arthritis three years before. In addition to the knee pain, the patient described several years of…

    TNF Blockade for SLE

    September 1, 2010

    Reckless approach versus missed opportunity?

    Vasculitis

    June 1, 2009

    A New perspective on when and how it begins

    Doest Rheumatoid Arthritis Take a Toll?

    November 15, 2013

    Exploring the Toll background

  • About Us
  • Meet the Editors
  • Issue Archives
  • Contribute
  • Advertise
  • Contact Us
  • Copyright © 2025 by John Wiley & Sons, Inc. All rights reserved, including rights for text and data mining and training of artificial technologies or similar technologies. ISSN 1931-3268 (print). ISSN 1931-3209 (online).
  • DEI Statement
  • Privacy Policy
  • Terms of Use
  • Cookie Preferences